Meclizine Dosage
For vertigo treatment in adults, the FDA-approved dosage of meclizine is 25 to 100 mg daily, administered orally in divided doses, depending on clinical response 1.
Standard Dosing Regimen
The typical approach is:
- Starting dose: 25 mg orally
- Range: 25-100 mg daily in divided doses
- Administration: Tablets must be swallowed whole 1
Critical Context: Limited Role in Vertigo Management
Meclizine should NOT be used routinely for benign paroxysmal positional vertigo (BPPV) 2. The 2008 American Academy of Otolaryngology guidelines explicitly recommend against routine treatment of BPPV with vestibular suppressants like meclizine, as there is no evidence these medications are effective as definitive primary treatment or as substitutes for repositioning maneuvers 2.
When Meclizine May Be Appropriate
Meclizine has a narrow therapeutic window:
- Short-term symptom relief only: For managing acute nausea and vomiting during severe vertigo attacks in conditions like Ménière's disease 3
- Not for BPPV: Repositioning maneuvers (like Epley) are the evidence-based treatment
- Limited duration: Should be prescribed for brief courses only, not chronic use
Important Safety Considerations
Fall Risk
Recent evidence shows meclizine use is associated with significantly increased fall risk 4. In a 2025 cohort study of over 800,000 patients with dizziness:
- Patients aged 18-64 years: 2.94-fold increased hazard of injurious falls
- Patients aged ≥65 years: 2.54-fold increased hazard of injurious falls
- Falls occurred within 60 days of meclizine prescription
Anticholinergic Effects
Use with caution in patients with 1:
- Asthma
- Glaucoma
- Prostatic hypertrophy
- Risk of urinary retention
Sedation
- Drowsiness is common 1
- Patients must avoid driving and operating machinery
- Avoid concurrent alcohol use 1
- May impair cognitive performance and working memory 5
Pediatric Dosing
Meclizine is FDA-approved only for adults 1. The drug label does not provide pediatric dosing recommendations, and safety/efficacy have not been established in children.
Comparative Effectiveness
A 2017 randomized trial found no difference between meclizine 25 mg and diazepam 5 mg for acute peripheral vertigo in the emergency department, with both groups showing similar improvement on visual analog scales 6.
Clinical Algorithm
Confirm diagnosis: Is this BPPV or another vestibular disorder?
- If BPPV → Perform repositioning maneuver (Epley), NOT meclizine
- If Ménière's or other vestibular disorder → Consider limited meclizine use
If prescribing meclizine:
- Start 25 mg orally
- May increase to 50-100 mg daily in divided doses based on response
- Limit to shortest duration necessary (days, not weeks)
- Counsel extensively on fall risk, especially in older adults
Reassess within 1 month to confirm symptom resolution and discontinue medication 2
The evidence strongly suggests meclizine is overused and guideline-discordant for most causes of dizziness, particularly BPPV, and carries meaningful harm through increased fall risk across all adult age groups.